ArticleHealthcare (Basel, Switzerland)2025
Preliminary Cost-Effectiveness of Re-Purposing β-Blockers as an Adjunct Treatment for Women with Triple-Negative Breast Cancer.
Melanie Lloyd et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.